该职位已失效,看看其他机会吧

免疫学总监(甫弘生物) (MJ014566)

6-8万·15薪
  • 上海浦东新区
  • 10年以上
  • 博士
  • 全职
  • 招1人

雇员点评标签

  • 工作环境好
  • 同事很nice
  • 团队执行强
  • 氛围活跃
  • 人际关系好
  • 交通便利
  • 非常锻炼人
  • 能学到东西

职位描述

特异性皮炎转化医学免疫学药理学PCC
主要职责:负责制定自免疾病开发策略,开展创新性的新项目立项和靶点验证,带领团队推进免疫管线项目至PCC及临床前开发。

· Develop and execute a strategic roadmap for immunology research, with a focus on I&I diseases (e.g., inflammatory bowel disease, atopic dermatitis, chronic spontaneous urticaria, asthma, COPD, multiple sclerosis, or other relevant indications).
Identify and prioritize high-value therapeutic targets and disease areas based on unmet medical needs, scientific feasibility, and market potential.

· Advance I&I projects as a project leader to PCC or further stages. Oversee the design and execution of preclinical studies to validate targets, evaluate candidate molecules, characterize their mechanism of action in relevant assays, and evaluate efficacy, safety, and PK/PD leveraging internal capabilities and CRO network.

· Collaborate with cross-functional teams to advance projects, including upstream and downstream teams such as antibody discovery/protein engineering, and CMC.

· Lead, manage, and mentor the Immunology team, ensuring smooth daily operation and people management, fostering a culture of innovation, collaboration, and scientific excellence, and meeting company’s overall strategic goals.
任职要求:
教育背景:Ph.D. in immunology or equivalent
相关经验:+8 year post-degree industrial experience and a track record of independent research
语言要求: Exceptional communication skills in English, with the ability to present complex scientific concepts to both technical and non-technical stakeholders
专业技能:
· Direct working experience in multiple R&D projects, with at least one project serving as a project team leader to complete the Concept-to-PCC cycle in early stage
research. Familiar with the key aspects of defining a successful biotherapeutic molecule.
· A deep understanding of immune system biology (e.g., Type 1, 2, and 17 inflammation, immune checkpoint, or immune regulation/tolerance) and mechanisms
of I&I diseases.
· Proficiency in current and emerging treatment paradigms for I&I diseases, including small molecules, biologics (e.g., monoclonal antibodies, bispecific antibodies,
cytokines), and novel modalities.
· Strong strategic thinking and ability to translate scientific insights into actionable research plans.
通用能力:
· Excellent leadership, team management, and mentorship skills, with a track record of building high-performing teams.
· Must be able to work in a team environment and have good interpersonal skills.
查看全部

工作地点

上海浦东新区海科路1288号

职位发布者

王梦/人事经理

立即沟通
公司Logo江苏恒瑞医药股份有限公司公司标签
恒瑞医药(股票代码:600276.SH,01276.HK)创立于1970年,是一家专注研发、生产及推广高品质药物的创新型国际化制药企业,聚焦肿瘤、代谢和心血管疾病、免疫和呼吸系统疾病以及神经科学等领域进行新药研发,是国内最具创新能力的制药龙头企业之一。五十余年来,恒瑞医药始终坚持为患者服务的初心,努力守护患者健康生活和生命质量,攻坚克难推进医药产业高质量发展。在美国制药经理人杂志公布的全球制药企业TOP50榜单中,恒瑞医药已连续6年上榜;国际知名咨询机构Citeline发布的全球TOP25管线规模制药公司榜单,恒瑞医药连续4年上榜,2025年自研管线数量位居全球第二;中国医药工业信息中心历年发布的“中国医药研发产品线最佳工业企业”,恒瑞医药已12次登顶榜首。
公司主页